The need to develop new strategies to combat diseases remains a major global challenge. This degree aims to enhance your employability and prepare you to tackle this challenge.
We’ll give you advanced training in the mechanisms underpinning a spectrum of infectious and non-infectious diseases, including viral, bacterial and parasitic infections, cancer, neurodegeneration, cardiovascular disease and chromosomal abnormalities. You’ll also explore current and emerging diagnostic and treatment strategies.
You’ll learn about the latest molecular, genetic and cellular approaches being used to understand, diagnose and treat human disease, including traditional methods such as polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA), and novel methods involving genome and proteome analysis.
You’ll also have the opportunity to investigate the role of the immune system in the response to infection and disease, covering topics such as innate and adaptive immunity, allergy and immune evasion.
If you choose to study at Leeds, you’ll join a faculty ranked 6th in the UK for its research impact in the recent Research Excellence Framework (REF 2014), and you’ll graduate with the solid base of scientific knowledge and specialist skills highly valued by employers.
On this course you’ll gain an overview of a range of modern techniques and methodologies that underpin contemporary biomolecular sciences. You’ll investigate five topic areas: molecular biology, structural biology, cell imaging and flow cytometry, high throughput techniques and transgenic organisms.
You’ll also apply your knowledge to an extended practical investigation in the form of a laboratory-based project, involving practical training in a range of modern molecular biology and protein engineering techniques such as gene cloning, PCR, mutagenesis, protein expression, protein purification and analysis.
To help you to develop and specialise, you’ll get substantial subject-specific training through an independent research project in an area of infection, immunity or human disease.
You’ll also take specialist taught modules covering topics such as infectious and non-infectious disease, advanced immunology, medical diagnostics and treatment of infectious diseases and cancer.
If you have previous experience of immunology, you could opt to investigate the structure, regulation and development of the pharmaceutical manufacturing sector, or explore aspects of human toxicology. These could include the actions of toxicants on the cardiovascular, immune and nervous systems, kidneys, liver and lungs, genetic toxicology and chemical carcinogenesis, and the effects of chemicals on fetal development.
In the final part of the course you'll work on an independent laboratory-based research project related to your course options. You’ll receive extensive training in experimental design, the practical use of advanced techniques and technologies, data analysis and interpretation, and will be assigned a research project supervisor who will support and guide you through your project.
These are typical modules/components studied and may change from time to time. Read more in our Terms and conditions.
You’ll have access to the very best learning resources and academic support during your studies. We’ve been awarded a Gold rating in the Teaching Excellence Framework (TEF, 2017), demonstrating our commitment to delivering consistently outstanding teaching, learning and outcomes for our students.
Your learning will be heavily influenced by the University’s world-class research as well as our strong links with highly qualified professionals from industry, non-governmental organisations and charities.
You’ll experience a wide range of teaching methods including formal lectures, interactive workshops, problem-solving, practical classes and demonstrations.
Through your research project and specialist modules, you’ll receive substantial subject-specific training. Our teaching and assessment methods are designed to develop you into a scientist who is able to think independently, solve problems, communicate effectively and demonstrate a high level of practical ability.
We use a variety of assessment methods: multiple-choice testing, practical work, data handling and problem solving exercises, group work, discussion groups (face-to-face and online), computer-based simulation, essays, posters and oral presentations.
The strong research element of the Infection, Immunity and Human Disease MSc, along with the specialist and generic skills you develop, mean you’ll graduate equipped for a wide range of careers.
Our graduates work in a diverse range of areas, ranging from bioscience-related research through to scientific publication, teacher training, health and safety and pharmaceutical market research.
Links with industry
We have a proactive Industrial Advisory Board who advise us on what they look for in graduates and on employability-related skills within our programmes.
We collaborate with a wide range of organisations in the public and commercial sectors. Many of these are represented on our Industrial Advisory Board. They include:
Industrial research placements
Some of our partners offer MSc research projects in their organisations, allowing students to develop their commercial awareness and build their network of contacts.
Professional and career development
We take personal and career development very seriously. We have a proactive Industrial Advisory Board who advises us on what they look for in graduates and on employability related skills within our courses.
Our dedicated Employability and Professional Development Officer ensures that you are aware of events and opportunities to increase your employability. In addition, our Masters Career Development Programme will support you to:
Tralee is currently seeking to recruit a high calibre and suitably qualified science graduate to undertake this Master of Research programme in the Department of Biological and Pharmaceutical Sciences at IT Tralee. Graduates holding a relevant Level 8 Honours Degree (second class honours or higher) are invited to submit an application. The successful applicants will be awarded a stipend of €700 per month for a maximum period of 18 months and the Institute will waive full fees for this funding period. Postgraduate students are expected to complete their studies full-time at the Institute.
Dr Oscar Goñi received his Degree in Chemistry from the University of Navarra (Spain), an MSc in Biochemistry and Molecular Biology from Complutense University of Madrid (Spain) and completed his PhD in Plant Protein Biochemistry at ICTAN-CSIC (Spain) and Complutense University of Madrid (Spain). Dr Goñi has previously worked as a Postdoctoral Research Fellow in the Max Planck Institute of Plant Breeding Research (Cologne). He is a protein biochemist with experience in the purification and characterization of functional proteins, enzymology and development of protein biomarkers. Dr. Goñi currently holds the position of Postdoctoral Researcher with Shannon ABC / Brandon Bioscience and specialises in the development of enzyme activities for the production of macro-algae derived oligosaccharides and chitin/chitosan derived oligosaccharides for crop protection and yield enhancement.
The United Nations’ and Agriculture Organization predicts that by 2050 the world will need to produce 70 percent more food than it does currently. Along with improving food storage and transport, increasing crop yields is seen as a primary solution. Salinity is one the major environmental stresses affecting crop production, particularly in arid and semi-arid areas. Most of the vegetable crops are salt sensitive, growing poorly in salinized soils due to the accumulation of toxic ions from prolonged irrigation regimes. A meaningful approach to increase crop yield and counteract salt stress would be the use of protein hydrolysate-based biostimulants, which are gaining interest worldwide. Nowadays, more than 90% of the protein hydrolysates market in agriculture is based on products obtained through chemical hydrolysis of proteins from animal origin. The production and use of new vegetable derived-protein hydrolysates with high plant biostimulant activity has become the focus of much research interest due to their lack of plant phytotoxicity, absence of degraded or biologically inactive amino acids or compatibility in the production of food for vegetarians. The commercial partner, Deltagen UK, aims to commercialise protein hydrolysate biostimulants with superior salinity inducing tolerance. The aim of this research is the development of an innovative system to produce protein hydrolysates from the defatted by product meals of flax, lentil and sesame seeds with the ability to biostimulate plant tolerance to salt stress. Novel protein hydrolysates will be produced using a cocktail of suitable proteases, they will be applied to tomato plants (cv. Micro-Tom) in a controlled growth room under salt stress conditions. Treatments will be assessed by comparing classic phenotypical parameters. Plant tissue will also be saved in order to assess other biochemical and molecular parameters such as stress related proteins and osmoprotectant metabolites.
The beginning of 21st century is marked by global scarcity of water resources, environmental pollution and increased salinization of soil and water. An increasing human population and reduction in land available for cultivation are two threats for agricultural sustainability. It has been estimated that worldwide 20% of total cultivated and 33% of irrigated agricultural lands are afflicted by high salinity. It has been projected that more than 50% of the arable land would be salinized by the year 2050. Use of optimized farm management practices such as shifting crop rotation or better irrigation systems can ameliorate yield reduction under salinity stress. However, its implementation is often limited because of cost and availability of good water quality. Several salt-tolerant varieties have been released, the overall progress of traditional breeding has been slow and has not been successful, as only few major determinant genetic traits of salt tolerance have been identified. The utilisation of agro-food processing wastes to generate value added products is an extremely convincing argument as it makes commercial and environmental sense. In addition, it is an excellent, demonstrable example of the European circular economy in action, a key objective of the H2020 research programme, turning waste into value and ultimately food for a growing population.
Three process variables will be studied in order to obtain the maximum degradation of seed proteins: incubation time, temperature and the initial concentration of meal protein. The Response Surface Methodology (RSM) will be used to reduce the cost and duration of experiments and allow for the observation of any interacting factors in the final process response. Amino acid and monosaccharide composition will be determined by sensitive high performance anion exchange chromatography with pulsed amperometric detection (HPAEC-PAD) according previous bibliography. Molecular weight distribution of protein hydrolysates will be characterized by protein electrophoresis (SDS-PAGE) and high performance size exclusion chromatography (HPSEC). The plant trials will involve 2 separate sets of experiments under unstressed and salt-stressed conditions respectively. Experiments will be carried out in a growth room with different concentration rates of different protein hydrolysates and the tomato variety Micro-Tom will be used. This extensive factorial experiment will be assessed by fruit yield, fruit quality, chlorophyll (SPAD measurement), MDH content (cell membrane integrity) and levels of protective compounds (proline and soluble carbohydrates). The presence of stress proteins such as HSPs will be determined using immunoblotting techniques (Western blot). RT-qPCR is another advanced laboratory technique that will be emp